Keith Al‐Hasani

1.6k total citations
29 papers, 815 citations indexed

About

Keith Al‐Hasani is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Keith Al‐Hasani has authored 29 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Genetics. Recurrent topics in Keith Al‐Hasani's work include Pancreatic function and diabetes (9 papers), Escherichia coli research studies (7 papers) and Epigenetics and DNA Methylation (6 papers). Keith Al‐Hasani is often cited by papers focused on Pancreatic function and diabetes (9 papers), Escherichia coli research studies (7 papers) and Epigenetics and DNA Methylation (6 papers). Keith Al‐Hasani collaborates with scholars based in Australia, Denmark and Hong Kong. Keith Al‐Hasani's co-authors include Ben Adler, Harry Sakellaris, John D. Boyce, Tamás Hatfaludi, Kumar Rajakumar, Assam El‐Osta, Roy M. Robins‐Browne, Patrick Collombat, Nouha Ben-Othman and Elisabet Gjernes and has published in prestigious journals such as PLoS ONE, Scientific Reports and Developmental Cell.

In The Last Decade

Keith Al‐Hasani

29 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Al‐Hasani Australia 15 232 228 226 216 186 29 815
GH McDowell Australia 20 315 1.4× 96 0.4× 58 0.3× 32 0.1× 86 0.5× 69 1.2k
Philippe Langella France 8 204 0.9× 494 2.2× 77 0.3× 30 0.1× 82 0.4× 8 934
Anne Jamet France 17 188 0.8× 405 1.8× 154 0.7× 52 0.2× 217 1.2× 36 943
Eleanor S. Metcalf United States 15 154 0.7× 240 1.1× 290 1.3× 25 0.1× 35 0.2× 26 1.2k
Ann E. Lin Canada 14 129 0.6× 334 1.5× 154 0.7× 33 0.2× 38 0.2× 21 803
Pascale Kharrat France 7 134 0.6× 294 1.3× 39 0.2× 35 0.2× 51 0.3× 9 669
Amélie de Vallée France 11 227 1.0× 433 1.9× 214 0.9× 56 0.3× 33 0.2× 14 772
K. Karlsson Sweden 12 123 0.5× 315 1.4× 208 0.9× 54 0.3× 68 0.4× 29 641
Clare K. Schmitt United States 8 160 0.7× 223 1.0× 391 1.7× 31 0.1× 32 0.2× 10 864
M. Ohnishi Japan 14 53 0.2× 182 0.8× 183 0.8× 15 0.1× 62 0.3× 28 658

Countries citing papers authored by Keith Al‐Hasani

Since Specialization
Citations

This map shows the geographic impact of Keith Al‐Hasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Al‐Hasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Al‐Hasani more than expected).

Fields of papers citing papers by Keith Al‐Hasani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Al‐Hasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Al‐Hasani. The network helps show where Keith Al‐Hasani may publish in the future.

Co-authorship network of co-authors of Keith Al‐Hasani

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Al‐Hasani. A scholar is included among the top collaborators of Keith Al‐Hasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Al‐Hasani. Keith Al‐Hasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maxwell, Scott, Jun Okabe, Harikrishnan Kaipananickal, et al.. (2024). Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells. Journal of the American Society of Nephrology. 35(6). 733–748. 9 indexed citations
2.
Al‐Hasani, Keith, Harikrishnan Kaipananickal, Scott Maxwell, et al.. (2024). EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors. Signal Transduction and Targeted Therapy. 9(1). 2–2. 13 indexed citations
3.
Khurana, Ishant, Natasha Howard, Scott Maxwell, et al.. (2023). Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 204. 110918–110918. 6 indexed citations
4.
Al‐Hasani, Keith, Ishant Khurana, Harikrishnan Kaipananickal, et al.. (2023). Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells. Clinical Epigenetics. 15(1). 101–101. 6 indexed citations
5.
El‐Osta, Assam, et al.. (2022). Microencapsulation-based cell therapies. Cellular and Molecular Life Sciences. 79(7). 351–351. 22 indexed citations
6.
Lunke, Sebastian, Scott Maxwell, Ishant Khurana, et al.. (2021). Epigenetic evidence of an Ac/Dc axis by VPA and SAHA. Clinical Epigenetics. 13(1). 58–58. 15 indexed citations
7.
Felisbino, Marina Barreto, Mark Ziemann, Ishant Khurana, et al.. (2021). Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways. Scientific Reports. 11(1). 2163–2163. 20 indexed citations
8.
Khurana, Ishant, Keith Al‐Hasani, Scott Maxwell, et al.. (2021). DNA methylation status correlates with adult β-cell regeneration capacity. npj Regenerative Medicine. 6(1). 7–7. 6 indexed citations
9.
Morahan, Belinda J., Keith Al‐Hasani, Victoria Corey, et al.. (2020). Human Aurora kinase inhibitor Hesperadin reveals epistatic interaction between Plasmodium falciparum PfArk1 and PfNek1 kinases. Communications Biology. 3(1). 701–701. 18 indexed citations
10.
Al‐Hasani, Keith, Prabhu Mathiyalagan, & Assam El‐Osta. (2019). Epigenetics, cardiovascular disease, and cellular reprogramming. Journal of Molecular and Cellular Cardiology. 128. 129–133. 24 indexed citations
11.
Mathiyalagan, Prabhu, Samuel T. Keating, Keith Al‐Hasani, & Assam El‐Osta. (2015). Epigenetic-Mediated Reprogramming of Pancreatic Endocrine Cells. Antioxidants and Redox Signaling. 22(16). 1483–1495. 2 indexed citations
12.
Chua, Eng Guan, Keith Al‐Hasani, M.J. Scanlon, Ben Adler, & Harry Sakellaris. (2015). Determinants of Proteolysis and Cell-Binding for the Shigella flexneri Cytotoxin, SigA. Current Microbiology. 71(5). 613–617. 4 indexed citations
13.
Al‐Hasani, Keith, Anja Pfeifer, Monica Courtney, et al.. (2013). Adult Duct-Lining Cells Can Reprogram into β-like Cells Able to Counter Repeated Cycles of Toxin-Induced Diabetes. Developmental Cell. 26(1). 86–100. 158 indexed citations
14.
Hatfaludi, Tamás, Keith Al‐Hasani, Lan Gong, et al.. (2012). Screening of 71 P. multocida Proteins for Protective Efficacy in a Fowl Cholera Infection Model and Characterization of the Protective Antigen PlpE. PLoS ONE. 7(7). e39973–e39973. 32 indexed citations
15.
Courtney, Monica, Anja Pfeifer, Keith Al‐Hasani, et al.. (2011). In vivo conversion of adult α ‐cells into β ‐like cells: a new research avenue in the context of type 1 diabetes. Diabetes Obesity and Metabolism. 13(s1). 47–52. 27 indexed citations
16.
17.
Al‐Hasani, Keith, et al.. (2007). Identification of novel immunogens in Pasteurella multocida. Microbial Cell Factories. 6(1). 3–3. 41 indexed citations
18.
Al‐Hasani, Keith, Jim Vadolas, Lucille Voullaire, Robert Williamson, & Panayiotis A. Ioannou. (2004). Complementation of α-thalassaemia in α-globin Knockout Mice with a 191 kb Transgene Containing the Human α-Globin Locus. Transgenic Research. 13(3). 235–243. 12 indexed citations
19.
Al‐Hasani, Keith, et al.. (2003). Development of a novel bacterial artificial chromosome cloning system for functional studies. Plasmid. 49(2). 184–187. 8 indexed citations
20.
Al‐Hasani, Keith, Kumar Rajakumar, Dieter Bulach, et al.. (2001). Genetic organization of the she pathogenicity island in Shigella flexneri 2a. Microbial Pathogenesis. 30(1). 1–8. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by GH McDowell Breakdown of academic impact, for papers by Philippe Langella Breakdown of academic impact, for papers by Anne Jamet Breakdown of academic impact, for papers by Eleanor S. Metcalf Breakdown of academic impact, for papers by Ann E. Lin Breakdown of academic impact, for papers by Pascale Kharrat Breakdown of academic impact, for papers by Amélie de Vallée Breakdown of academic impact, for papers by K. Karlsson Breakdown of academic impact, for papers by Clare K. Schmitt Breakdown of academic impact, for papers by M. Ohnishi
Rankless by CCL
2026